ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Avexitide for Treatment of Post-Bariatric Hypoglycemia

ClinicalTrials.gov ID: NCT06747468

Public ClinicalTrials.gov record NCT06747468. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 8:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Avexitide in Participants With Post-Bariatric Hypoglycemia

Study identification

NCT ID
NCT06747468
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amylyx Pharmaceuticals Inc.
Industry
Enrollment
75 participants

Conditions and interventions

Interventions

  • Avexitide Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 28, 2025
Primary completion
Feb 28, 2026
Completion
Sep 30, 2026
Last update posted
Mar 3, 2026

2025 – 2026

United States locations

U.S. sites
21
U.S. states
13
U.S. cities
19
Facility City State ZIP Site status
Stanford Health Care - Endocrinology Clinic Stanford California 94304
University of Colorado Health Anschutz Medical Campus Aurora Colorado 80045-2541
East Coast Institute for Research Jacksonville Florida 32216
Hanson Diabetes Center Port Charlotte Florida 33952-6722
Georgia Clincal Research Lawrenceville Georgia 30044
Cotton-O'Neil Diabetes and Endocrinology Center Topeka Kansas 66606-2806
Brigham and Women's Hospital Boston Massachusetts 02115
Joslin Diabetes Center Boston Massachusetts 02215-5306
NYC Health + Hospitals/Queens - BRANY New Hyde Park New York 11042-1214
Duke Center for Metabolic and Weight Loss Surgery Durham North Carolina 27704-2726
Centricity Research Morehead City Multispecialty Morehead City North Carolina 28557-3126
Cleveland Clinic Cleveland Ohio 44195-0001
Penn Medicine University City Philadelphia Pennsylvania 19104
Vanderbilt Weight Loss Center Nashville Tennessee 37212-3609
Endocrine and Psychiatry Center Houston Texas 77095-2856
Southern Endocrinology & Diabetes Associates Mesquite Texas 75149
UT Health San Antonio San Antonio Texas 78229-3931
Diabetes and Gandular Disease Clinic San Antonio Texas 78229-4801
Consano Clinical Research Shavano Park Texas 78231-1281
Texas Valley Clinical Research, LLC Weslaco Texas 78596-7288
UWHealth - Junction Rd Medical Center Endocrinology Clinic Madison Wisconsin 53717-2656

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06747468, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 3, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06747468 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →